CHUNG SHAN MEDICAL UNIVERSITY Patent applications |
Patent application number | Title | Published |
20130296294 | TREATMENT AND/OR PREVENTION OF PARKINSON'S DISEASE DEMENTIA WITH CEFTRIAXONE - Disclosed herein is a method for treatment of a human subject having or suspected of having Parkinson's disease dementia, which includes administering to the human subject ceftriaxone at a daily dosage ranging from about 1.5 mg to about 35 mg per kilogram of a body weight of the human subject. | 11-07-2013 |
20120129822 | COMPOSITION CONTAINING DIOSGENIN AND USE THEREOF TO IMPROVE AT LEAST ONE OF COGNITIVE DEFICITS ASSOCIATED WITH MENOPAUSAL SYNDROME - Disclosed herein is a composition for improving at least one of cognitive deficits associated with menopausal syndrome, which includes diosgenin. Also disclosed herein is a method for improving at least one of cognitive deficits associated with menopausal syndrome in a subject via administering the aforesaid composition. | 05-24-2012 |
20110232533 | METHOD FOR PRODUCING CALCIUM SILICATE-BASED BONE CEMENT - One aspect of the present invention provides a method for producing calcium silicate-based bone cement, including the steps of mixing calcium salt with silicohydrides to form a first mixture; processing the first mixture with a sol-gel process to form a second mixture; heating the second mixture to form a dried mixture; grinding the second mixture into powder; and adding the powder to water or phosphate solution. | 09-29-2011 |
20110160260 | Method of Treating a Neurodegenerative Disorder - The present invention provides a method of treating a neurodegenerative disorder in a patient, comprising administration to the patient a therapeutically effective amount of D-cycloserine and its derivatives. | 06-30-2011 |
20100266603 | Monoclonal Antibody Specific to Ochratoxin A - This invention provides a monoclonal antibody specific to ochratoxin A and methods of assaying the level of ochratoxin A in food and feed. | 10-21-2010 |
20100221368 | Methods for Inhibiting Cytokines - A method for inhibition a cytokine, transgluaminase type 2 (TG2) or matrix metalloproteinase 9 (MMP-9) was provided. | 09-02-2010 |
20100196514 | CALCIUM SILICATE-BASED COMPOSITE CEMENT AND METHODS FOR THE PREPARATION - The present invention provides a method for producing calcium silicate-based bone cement and a composition produced by the method. It further provides a novel composition for bone tissue repair. | 08-05-2010 |
20090299233 | Device for Measuring Functional Reach - A device for measuring functional reach is disclosed, which comprises three parts: a support, one end thereof being attached to an object; a ruler, one end thereof being connected to the support; and a vernier, being connected to the ruler and moving on the ruler forward and backward. The invention is used for a functional evaluation test for measuring balance. | 12-03-2009 |
20090214683 | Extracts of Sacred Water Lotus for the Treatment of Cancer - The present invention provides | 08-27-2009 |
20090198345 | CALCIUM SILICATE-BASED COMPOSITE CEMENT AND MANUFACTURING METHOD THEREOF - The present invention provides a method for producing calcium silicate-based bone cement and a composition produced by the method. It further provides a novel mixture for bone tissue repair. | 08-06-2009 |
20080311090 | Methods for inhibition of proliferative disease, including hepatocellular carcinoma - The present invention is related to a method for modulating expression of protein kinase C-alpha associated with proliferative diseases. The invention further relates to a screening method utilizing the association between transcription factors (MZF-1 and Elk-1) and their DNA binding element (PKC-.alpha. promoter) to identify novel anticancer agents. | 12-18-2008 |